There are currently 95 clinical trials in Chandler, Arizona looking for participants to engage in research studies. Trials are conducted at various facilities, including GSK Investigational Site, Arizona Eye Center, Chandler Regional Medical Center and Ironwood Cancer and Research Centers. Whether you're a healthy volunteer looking to participate in paid medical research or seeking trials related to a specific condition, the city provides a diverse range of opportunities near you.
Genetic Risk Stratification for Primary Prevention of CAD in Men and Pre & Post-menopausal Women
NCT05169840
Recruiting
The investigators propose to genotype males and females at age 40 years and older, who are asymptomatic and without known heart disease (N=2000). DNA from a blood sample will be genotyped for millions of genetic risk variants for CAD by Baylor College of Medicine Human Genome Sequencing Center Clinical Laboratory (HGSC-CL) in a CLIA-approved laboratory. The overall objective after 2 years is to determine if genetic screening for risk of CAD in asymptomatic men and women has the discriminatory p... Read More
Gender:
All
Ages:
Between 40 years and 60 years
Trial Updated:
11/22/2023
Locations: Chandler Regional Medical Center, Chandler, Arizona
Conditions: Coronary Artery Disease, Genetic Predisposition to Disease
Register for Updates
Tigulixostat, Phase 3 Study, Allopurinol Controlled in Gout Patients
NCT05586971
Recruiting
The aim of this 12-month randomized multi-regional double-blind parallel group allopurinol and placebo-controlled phase 3 study is to assess the efficacy and safety of three different doses of Tigulixostat in gout patients with hyperuricemia.
Gender:
All
Ages:
Between 18 years and 85 years
Trial Updated:
10/17/2023
Locations: Arizona Research Clinic, PLLC, Chandler, Arizona
Conditions: Gout, Hyperuricemia, Gout Flare, Tophi
Register for Updates
Saroglitazar Magnesium 4 mg in the Treatment of NAFLD in Women With PCOS (EVIDENCES VII)
NCT03617263
Recruiting
This is a multicenter, phase 2A, randomized, double-blind, placebo-controlled study designed to evaluate the efficacy and safety of Saroglitazar Magnesium in women with well characterized PCOS.
Gender:
Female
Ages:
Between 18 years and 45 years
Trial Updated:
10/06/2023
Locations: Dr.Anita Kohli, Chandler, Arizona
Conditions: Non-alcoholic Fatty Liver Disease in Women With PCOS
Register for Updates
A Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Miricorilant in Patients With Presumed Nonalcoholic Steatohepatitis (NASH)
NCT05117489
Recruiting
This phase 1b, Open-Label Study is to assess the safety, efficacy of miricorilant in patients with presumed Nonalcoholic Steatohepatitis (NASH)
Gender:
All
Ages:
Between 18 years and 75 years
Trial Updated:
09/28/2023
Locations: Site 207, Chandler, Arizona
Conditions: Nonalcoholic Steatohepatitis (NASH)
Register for Updates
Non-Invasive Quantification of Liver Health in NASH (N-QUAN)
NCT04054310
Recruiting
To evaluate, in patients with suspected NASH referred for liver biopsy, the diagnostic performance of CT1 at discriminating those with NAS≥4 & F≥2 from those without.
Gender:
All
Ages:
Between 18 years and 75 years
Trial Updated:
09/07/2023
Locations: Arizona Liver Health, Chandler, Arizona
Conditions: NASH - Nonalcoholic Steatohepatitis
Register for Updates
Personalized Therapy Study - Intrinsic Antitachycardia Pacing Post-Approval Study (iATP PAS)
NCT04496518
Recruiting
Medtronic is sponsoring the Intrinsic Antitachycardia Pacing Post-Approval Study (iATP PAS) to further confirm safety and effectiveness of ventricular iATP therapy in routine clinical practice, following commercial release of iATP-capable devices. The iATP PAS is conducted within Medtronic's Product Surveillance Registry platform (NCT01524276).
Gender:
All
Ages:
All
Trial Updated:
08/29/2023
Locations: Southwest EP, Chandler, Arizona
Conditions: Ventricular Tachycardia
Register for Updates
Personalized Therapy Study - HFRS (TriageHF) Post Approval Study
NCT04489225
Recruiting
Medtronic is sponsoring the HFRS PAS to evaluate the HFRS feature (TriageHF) when used in routine clinical practice following commercial release. The HFRS PAS is conducted within Medtronic's Product Surveillance Registry (PSR) platform.
Gender:
All
Ages:
All
Trial Updated:
08/29/2023
Locations: Southwest EP, Chandler, Arizona
Conditions: Heart Failure
Register for Updates
Playing Games to Learn About Children's Vaccines Project
NCT05984849
Recruiting
This proposed study aims to conduct timely research that promotes vaccine confidence and vaccination of two strongly recommended vaccines with suboptimal uptake rates: Human papillomavirus (HPV) and COVID-19 in vulnerable and underserved youth aged 11-14.
Gender:
All
Ages:
Between 11 years and 14 years
Trial Updated:
08/02/2023
Locations: Community, Chandler, Arizona
Conditions: HPV, COVID-19, Vaccine-Preventable Diseases
Register for Updates
Study of the Use of Orthopulse Photobiomodulation
NCT05650359
Recruiting
This PMCF study evaluates the safety and performance of OrthoPulse photobiomodulation to accelerate tooth movement during alignment with fixed appliances.
Gender:
All
Ages:
18 years and above
Trial Updated:
07/26/2023
Locations: Private Practice, Chandler, Arizona
Conditions: Orthodontics
Register for Updates
Buccal Film vs IV Palonosetron for Prevention of CINV in Cancer Patients Receiving MEC
NCT05199818
Recruiting
The phase 3 study is to compare the efficacy and safety of palonosetron, a long-acting 5-HT3 receptor antagonist, by buccal film delivery compared to IV injection for the prevention of chemotherapy-induced nausea and vomiting. Subjects receive a single dose of palonosetron prior to moderately emetogenic chemotherapy.
Gender:
All
Ages:
18 years and above
Trial Updated:
01/19/2023
Locations: Ironwood Cancer & Research Centers, Chandler, Arizona
Conditions: Chemotherapy-induced Nausea and Vomiting
Register for Updates
AngioSafe Peripheral CTO Crossing System Study (RESTOR-1 Study)
NCT04663867
Recruiting
The study is designed to evaluate the safety and efficacy of the AngioSafe Peripheral CTO Crossing System.
Gender:
All
Ages:
22 years and above
Trial Updated:
11/22/2022
Locations: Dignity Health - Chandler Regional Medical Center, Chandler, Arizona
Conditions: Peripheral Artery Occlusion, Peripheral Arterial Disease
Register for Updates